Macrolides in the treatment of children with Mediterranean spotted fever;I macrolidi nella terapia della febbre bottonosa del Mediterraneo in età pediatrica

Infezioni in Medicina

Volumn 10, Issue 3, 2002, Pages 145-150

  Cascio, Antonio ^a   Colomba, Claudia ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Macrolides; Mediterranean spotted fever

Indexed keywords

AZITHROMYCIN; CHLORAMPHENICOL DERIVATIVE; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN STEARATE; JOSAMYCIN; MACROLIDE; TETRACYCLINE DERIVATIVE;

APLASTIC ANEMIA; BLOOD TOXICITY; BOUTONNEUSE FEVER; CHILD; CHILDHOOD DISEASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GRAY BABY SYNDROME; HEMOLYTIC ANEMIA; HUMAN; INFANT DISEASE; REVIEW; STATISTICAL SIGNIFICANCE; TOOTH COLOR; TOOTH DISEASE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BOUTONNEUSE FEVER; CHILD; CHILD, PRESCHOOL; CHLORAMPHENICOL; CLARITHROMYCIN; FEMALE; HUMANS; INFANT; ITALY; MACROLIDES; MALE; RANDOMIZED CONTROLLED TRIALS; SICILY; TETRACYCLINES; TREATMENT OUTCOME;

EID: 0036397714     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Gross Ellis M., Yagupsky P., Toroh V., et al. Resurgence of Mediterranean Spotted Fever. Lancet 2,1107, 1981.
2. Segura-Porta F., Fonte-Crues B. Resurgence of Mediterranean spotted fever in Spain. Lancet 2, 280, 1982.
3. Segura-Porta F., Font-Creus B., Espejo-Arenas E., et al. New trends in Mediterranean spotted fever. Eur. J. Epidemiol. 5, 438-443, 1989.
4. Mansueto S., Tringali G., Walker DH. Widespread simultaneous increase in the incidence of Spotted Fever Group Rickettsioses. Journal. Infect. Dis. 154, 539-540, 1986.
5. Cascio A., Dones P., Romano A., et al. Clinical and laboratory findings of boutonneuse fever in Sicilian children. Eur. J. Pediatr. 157, 482-486, 1998.
6. Gilot B., Laforge ML., Pichot J., et al. Relationships between the Rhipicephalus sanguineus complex ecology and Mediterranean spotted fever epidemiology in France. Europ. J. Epidemiol. 6, 357-362, 1990.
7. La Scola B., Raoult D. Diagnosis of Mediterranean spotted fever by cultivation of Rickettsia conorii from blood and skin samples using the centrifugation-shell vial technique and by detection of R. conorii in circulating endothelial cells: a 6-year follow-up. J. Clin. Microbiol. 34, 2722-2727, 1996.
8. Feigin R.D., Snider R.L., Edwards M.S. Rickettsioses, In: Textbook of pediatric infectious diseases (Philadelphia Saunders, 3d ed.) 1992, pp 1853-1855.
9. American Academy of Pediatrics Committee on Drugs. Requiem for tetracycline. Pediatrics. 55, 142-143, 1975.
10. Luzzato L. G6PD deficiency and haemolytic anemia, In: Hematology of infancy and childhood (Nathan G., Oski F.A., Eds). 674-731, 1993.
11. Craft A.W., Brockleband J.T., Hey E.N., et al. The "gray toddler": chloramphenicol toxicity. Arch. Dis. Child. 49, 235-237, 1974.
12. Wallerstein R.O., Condit P.K., Kasper C.K., et al. Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA 208, 2045-2050, 1969.
13. Ives T.J., Marston E.L., Regnery R.L., et al. In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected Vero cell monolayers. J. Antimicrob. Chemother. 45, 305-310, 2000.
14. Ives T.J., Manzewitsch P., Regnery R.L., et al. In vitro susceptibilities of Bartonella henselae, B.quintana, B.elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayers. Antimicrob. Agents Chemother. 41, 578-582, 1997.
15. Rolain J.M., Maurin M., Vestris G., et al. In vitro susceptibilities of 27 Rickettsiae to 13 antimicrobials. Antimicrob. Agents Chemother. 42, 1537-1541, 1998.
16. Munoz-Espin T., Lopez-Pares P., Espejo-Arenas E., et al. Eryhromycin versus tetracycline for treatment of Mediterranean spotted fever. Arch. Dis. Child. 61, 1027-1029, 1986.
17. Meloni G., Meloni T. Azithromycin vs doxycycline for Mediterranean spotted fever. Pediatr. Infect. Dis. J. 15, 1042-1044, 1996.
18. Bella F., Font B., Uriz S., et al. Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever. Antimicrob. Agents Chemother. 34, 937-938, 1990.
19. Cascio A., Colomba C., Di Rosa D., Salsa L., Di Martino L., Titone L. Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children. A randomized controlled trial. Clin. Infect. Dis. 33, 409-411, 2001.
20. Cascio A., Colomba C., Antinori S., Paterson D., Titone L. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children. A randomized controlled trial. Clin. Infect. Dis. 34,154-158, 2002.